WO2020082786A1 - 基于数据处理的用药监控方法及装置 - Google Patents

基于数据处理的用药监控方法及装置 Download PDF

Info

Publication number
WO2020082786A1
WO2020082786A1 PCT/CN2019/094997 CN2019094997W WO2020082786A1 WO 2020082786 A1 WO2020082786 A1 WO 2020082786A1 CN 2019094997 W CN2019094997 W CN 2019094997W WO 2020082786 A1 WO2020082786 A1 WO 2020082786A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug
drugs
monitored
unit
prescription
Prior art date
Application number
PCT/CN2019/094997
Other languages
English (en)
French (fr)
Inventor
袁刚
Original Assignee
平安医疗健康管理股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 平安医疗健康管理股份有限公司 filed Critical 平安医疗健康管理股份有限公司
Publication of WO2020082786A1 publication Critical patent/WO2020082786A1/zh

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Definitions

  • the present application relates to the field of medical technology, and in particular to a method and device for monitoring medication based on data processing.
  • Various medication monitoring mechanisms are used to monitor medication for various medical units, including but not limited to medical units (or representatives of medical units) such as various hospitals, departments of various hospitals, various clinics, and even various physicians.
  • the evaluation of the medication standard of each medical unit mainly adopts the sub-average prescription standard, that is, the average cost of prescriptions calculated each time (abbreviated as the sub-average prescription cost) is used as the evaluation standard of each medical unit.
  • the evaluation criteria for the above-mentioned average prescription cost are calculated by dividing the total prescription by the number of prescriptions.
  • the use of sub-average prescription cost as the evaluation standard of each medical unit has led each medical unit to be evaluated in order to avoid large prescriptions.
  • the number of prescription days is reduced to reduce the average prescription cost, or a single prescription is broken down by breaking down the prescription.
  • the embodiments of the present application provide a medicine monitoring method and device based on data processing.
  • the operation is simple, the accuracy of the medicine monitoring of the medical unit can be improved, the reliability of the medicine monitoring of the medical unit can be improved, and the applicability is stronger.
  • an embodiment of the present application provides a medication monitoring method based on data processing.
  • the method includes:
  • the medication standard threshold corresponding to the medical unit to be monitored it is determined whether the medication of the medical unit to be monitored meets the standard.
  • an embodiment of the present application provides a medication monitoring device based on data processing.
  • the medication monitoring device includes:
  • the data acquisition unit is used to acquire the medication prescription of the medical unit to be monitored
  • the medicine information processing unit is used to obtain the medicine information of the medicines included in the medicine prescription obtained by the data acquisition unit, and determine the average daily drug cost of the medicines of the medicines according to the medicine information of the medicines;
  • the above-mentioned drug information processing unit is also used to determine the target drug in the above-mentioned drug prescription based on the average daily drug cost of the above-mentioned drugs, and determine the target drug in the above-mentioned drug prescription based on the drug information of the above-mentioned drugs Target drug ratio;
  • the medication evaluation unit is used to determine whether the medication of the medical unit to be monitored meets the standard according to the target drug ratio determined by the drug information processing unit and the medication standard threshold corresponding to the medical unit to be monitored.
  • an embodiment of the present application provides a terminal device.
  • the terminal device includes a processor and a memory, and the processor and the memory are connected to each other.
  • the memory is used to store a computer program that supports the terminal device to execute the method provided in the first aspect and / or any possible implementation manner of the first aspect
  • the computer program includes program instructions
  • the processor is configured to call the foregoing Program instructions to execute the method provided in the first aspect and / or any possible implementation manner of the first aspect.
  • an embodiment of the present application provides a computer-readable storage medium storing a computer program, the computer program including program instructions, which when executed by a processor causes the processor to execute The method provided in the foregoing first aspect and / or any possible implementation manner of the first aspect.
  • FIG. 1 is a schematic flowchart of a medication monitoring method based on data processing provided by an embodiment of the present application
  • FIG. 2 is another schematic flow chart of a method for monitoring medication use based on data processing provided by an embodiment of the present application
  • FIG. 3 is a schematic structural view of an embodiment of a medication monitoring device based on data processing provided by an embodiment of the present application;
  • FIG. 4 is a schematic structural diagram of an embodiment of a terminal device provided by an embodiment of the present application.
  • the determination of valuable medicines in various regions is to determine the medicines whose unit price of the smallest packaging unit (such as a bottle, a pack, a box or a bag, etc.) exceeds a certain threshold as valuable medicines.
  • this method does not take into account the number of days of use of the unit price of the smallest packaging unit for the determination of valuable drugs, so the possible drawback is that the same unit price of the drug or a low-priced drug or a high-priced drug is used for different days. Inverted situation with higher unit price but lower average daily price.
  • the price of a single drug box is 300 yuan, which is judged as a valuable drug according to the current method of judging precious drugs in various regions; the box of this valuable drug can be used for 30 days, that is, the average daily price of the drug is 10 yuan / day.
  • the price of another single drug box is 120 yuan, which is judged to be non-precious drug according to the current method of judging precious drugs in various regions; the box of this drug can be used for 3 days, that is, the average daily price of the drug is 40 yuan / day. It can be seen that the average daily price of non-precious drugs judged according to the current method of judging precious drugs in various regions exceeds the average daily price of precious drugs. Obviously, this judgment method has a low accuracy rate for the evaluation of precious drugs, which makes precious There are large loopholes in the assessment of drugs.
  • the target medicine provided by the embodiment of the present application may be a valuable medicine, and the determination method of the valuable medicine here is different from the above-mentioned current determination method of the valuable medicine in each region.
  • the valuable drug may be a drug whose daily average drug cost is high among various types of drugs included in the prescription and is ranked high in the daily average drug cost of various types of drugs included in the prescription.
  • the following will take precious medicines as an example and describe in conjunction with the data processing based warning method for exceeding the warning of medicines provided by the embodiments of the present application.
  • the proportion of target drugs can be explained by taking the proportion of valuable drugs as an example, which will not be repeated below.
  • the embodiments of the present application provide a medication monitoring method based on data processing, which can be based on the proportion of valuable drugs in medical units (or representatives (or teams) of medical units) of various hospitals, various hospital departments, various clinics and even various physicians To evaluate whether the medications of various medical units (including hospitals, departments, clinics or physicians) meet the standards (or are reasonable).
  • medical units or representatives (or teams) of medical units
  • various hospital departments various clinics and even various physicians
  • the assessment dimensions represented by the representatives of the above-mentioned hospitals, departments of various hospitals, clinics, and even doctors or other medical units or medical units will be described using the evaluation dimension of the medical unit as an example, and will not be described below.
  • the medication prescriptions provided in the embodiments of the present application may include prescriptions issued by various doctors of various medical units for the symptoms of various patients, or referred to as prescriptions prescribed by various physicians for the symptoms of various patients, or prescription papers, etc., in There are no restrictions.
  • the prescription will be described as an example below.
  • the prescriptions issued by various doctors in various medical units may include but are not limited to the time of prescription issuance, prescription number, department number, patient personal information, drug details and physician signature, which can be determined according to the actual application scenario. There are no restrictions.
  • each prescription will contain the details of the medicine issued by the medical unit, including but It is not limited to the name of the drug, the amount of the drug, the method of using the drug, and the number of days the drug is used. Based on the details of the drugs included in each prescription, it can be determined that the single-drug daily average drug cost is high and the top ranked drugs are valuable drugs, and then the proportion of the total cost of drugs in all prescriptions based on the cost of precious drugs (i.e. expensive Drug ratio) to determine whether the medication is reasonable.
  • the evaluation of the medical standard of each medical unit was carried out using the average daily drug cost (ie, the average daily drug cost of a single drug) corresponding to each type of drug, while also considering the The cost ratio is simple, and the operation is simple and can better and more comprehensively cover the medication monitoring of each prescription of the medical unit.
  • the monitoring of medication use of each medical unit is more accurate and in place, which can improve the accuracy of drug monitoring of each medical unit and have higher applicability.
  • the medical unit's medication usage can be monitored daily based on the medical unit's valuable drug ratio when the medical unit's medication monitoring is performed, and the medical unit's precious drug ratio can be settled daily, based on the daily valuable drug ratio Monitor the use of medicine by medical units.
  • a comprehensive evaluation of the medication use of the medical unit based on the cumulative multi-day medication monitoring situation such as a week, month, quarter or One year, etc., can be determined according to the actual application scenario, without limitation.
  • the following will be based on the calculation of the average daily drug cost and the proportion of valuable drugs for various types of drugs on any day (for convenience, the following will be explained as an example), which can be based on the daily proportion of valuable drugs / Or the average daily drug cost evaluates the medication situation of the medical unit as an example, and describes the medication monitoring method based on data processing provided in the embodiments of the present application.
  • the medicine monitoring method based on data processing can be executed by terminal devices associated with medicine monitoring units such as the Drug Administration, the Health Commission, the Health and Health Commission, and medical claims units.
  • medicine monitoring units such as the Drug Administration, the Health Commission, the Health and Health Commission, and medical claims units.
  • the above medicine monitoring units are used for each Clients and / or human-computer interaction devices for medical unit monitoring of medications are not limited here.
  • the terminal device will be taken as an example for description below.
  • FIG. 1 is a schematic flowchart of a medication monitoring method based on data processing provided by an embodiment of the present application.
  • the medication monitoring method based on data processing provided by the embodiments of the present application can be described by the implementation manners provided in the following steps S11 to S14.
  • the above-mentioned medical unit to be monitored may be any medical unit monitored by the medication monitoring unit, which may be specifically determined according to actual application scenarios, and is not limited herein.
  • any medical unit may be monitored by the medication monitoring unit, so the selected monitoring object may be the medical unit to be monitored.
  • the medical unit to be monitored will be described as an example below.
  • the medication prescriptions of the above medical units may include all medication prescriptions generated by the medical unit to be monitored within a single day.
  • all medication prescriptions generated by the above-mentioned medical unit to be monitored within a single day time can be explained by taking a single day prescription as an example.
  • the single-day prescription of the above medical unit may refer to all prescriptions issued on any day of the medical unit, including but not limited to all prescriptions issued by all doctors in all departments of the hospital within a single day, and one of the hospitals within a single day All the prescriptions issued by all the doctors in the department, or all the prescriptions issued by a doctor in a certain department of the hospital within a single day.
  • the specific conditions indicated by the above single-day prescriptions are based on the evaluation dimension of the medical unit's medication monitoring in the actual application scenario (for example, the medical unit's medication monitoring, the medical unit's medication monitoring for a medical department, or the medical unit's medication monitoring A certain doctor in a department carries out medication monitoring, etc.), and it is not restricted here.
  • the following will take all prescriptions issued by all doctors in all departments of the hospital within a single day as an example, hereinafter referred to as a single day prescription.
  • the terminal device can be docked with the data system of the medical unit to be monitored to obtain the access qualification of the data system of the medical unit to be monitored, and from the medical system to be monitored based on the data system access qualification of the medical unit to be monitored
  • the unit's data system obtains the prescription of the medical unit to be monitored, for example, the single-day prescription of the medical unit to be monitored.
  • the terminal device may also screen out the medical claim data such as the single-day prescription of the medical unit from the medical claim data.
  • the terminal device can also obtain prescription data such as the single-day prescription of the medical unit to be monitored from the medical records of patients in each medical unit based on big data analysis, and so on.
  • the terminal device may obtain a single-day prescription of the medical unit to be monitored based on any data acquisition path other than the above-mentioned data acquisition method, which may be determined according to actual application scenarios, without limitation.
  • any single prescription of the medical unit to be monitored here can include the details of the drugs prescribed in the prescription, including but not limited to the name of the drug, the amount of the drug, the way of using the drug (or the method of taking the drug, etc.) ) And the number of days the drug is used can be determined according to the actual application scenario, and is not limited here.
  • the drug information of each drug included in all prescriptions of the single-day prescription of the medical unit to be monitored may be determined, wherein the drug information of any drug includes but not Limited to the amount of medicine and days of medicine use.
  • the drug information of each drug included in all prescriptions in the single-day prescription of the medical unit to be monitored the total number of drugs included in the single-day prescription of the medical unit to be monitored, the total amount of drugs, and the total number of days of drug use, etc. can be determined.
  • the drug amount of any of the above drugs is the price of a single drug by multiplying the unit price and quantity of any drug.
  • the above-mentioned total number of medicines represents the total number of medicines used in all prescriptions in a single-day prescription after accumulation.
  • the total amount of the above drugs is based on the unit price and quantity of each drug included in the single-day prescription to obtain the drug amount of the single drug, and then the drug amounts of all the drugs included in the single-day prescription are accumulated to obtain the drugs of all drugs
  • the total price ie the total amount of medicine.
  • the total number of days of use of the above drugs is the cumulative value of the number of days of use of each drug in all drugs in a single-day prescription.
  • the average daily drug cost of the single-day prescription of the medical unit to be monitored represents the average cost of all drugs included in the single-day prescription of the medical unit to be monitored.
  • the average daily drug cost can be explained. Among them, the average daily drug cost of the single-day prescription of the medical unit to be monitored can be calculated based on the following formula (1):
  • Average daily drug cost total drug / total days of drug use.
  • the total amount of medicines in the above formula (1) is the total price of all medicines obtained by accumulating the medicine amounts of all medicines in a single day prescription
  • the total number of days of use of the above medicines is the number of days of use of each medicine in all medicines in a single day prescription Accumulated value.
  • the average daily drug cost of the medical unit is the average daily drug cost of the medical unit.
  • the terminal device can also calculate the daily average drug cost of each type of drug in the single-day prescription of the medical unit.
  • the daily average drug cost of any kind of drugs will be described below as an example.
  • the medicine information of all kinds of medicines included in all medicine prescriptions can be obtained, and the above-mentioned medicine information includes at least the medicine amount and the days of medicine use. Determine the total drug amount of any drug in the above single-day prescription and the total number of days of drug use of any of the above-mentioned drugs according to the drug information of each type of drug in the above single-day prescription.
  • the total number of days of drug use for a class of drugs determines the average daily drug cost per drug for any of the above-mentioned types of drugs to obtain the average daily drug cost for each drug of the above categories.
  • the calculation of the average daily drug cost of any of the above drugs can meet the following formula (2):
  • the total price of any kind of medicines in the above formula (2) is the total price of a single medicine of all medicines prescribed in a single day (for convenience of description to describe any kind of medicine), the total price of the single medicine
  • the total number of days of use of any type of drug is the cumulative value of the number of days of use of that type of drugs in all drugs prescribed in a single day.
  • the average daily single-drug drugs of various types of drugs in the single-day prescription of the medical unit to be monitored can be determined
  • the cost can be used to determine the valuable drugs in a single-day prescription based on the average daily drug cost of each type of drug.
  • the daily average drug cost threshold corresponding to the single-day prescription of the unit to be monitored can be determined, and the above-mentioned various Among the class of drugs, drugs whose average daily drug cost is greater than or equal to the above-mentioned daily average drug cost threshold are determined to be valuable drugs in the single-day prescription of the medical unit to be monitored.
  • the valuable drug refers to a drug whose daily drug cost per drug is higher than the daily drug cost per drug prescribed for a single day and that the daily drug cost per drug is greater than or equal to the threshold of the daily drug cost per drug.
  • the average daily drug cost of various drugs can be sorted in order from high to low, and then the average daily drug cost of single drug
  • the top part (for example, 20%) of the medicines with the lowest average daily drug cost of the single drug is determined as the average daily drug cost threshold for the single drug.
  • the average daily drug cost of each drug in this part (that is, 20%) of the drugs The drug cost is greater than or equal to the single drug daily average drug cost threshold, and then this part (ie 20%) of the drug can be determined as a valuable drug.
  • the average daily drug cost of a single drug is determined to be x yuan / day (that is, the average daily drug cost threshold for a single drug) according to the average daily drug cost of various drugs, for example, 11 yuan / day Of medicines are valuable medicines.
  • x yuan / day that is, the average daily drug cost threshold for a single drug
  • 11 yuan / day Of medicines are valuable medicines.
  • 20% of all medicines included in the single-day prescription of the medical unit to be monitored are medicines with an average daily drug cost of 11 yuan / day or more, and these medicines are valuable medicines.
  • the total amount of drugs of all drugs in the above-mentioned drug prescription and the total amount of valuable drugs of the above-mentioned valuable drugs included in the above-mentioned drug prescription can be determined.
  • the proportion of valuable drugs in the single-day prescription of the medical unit to be monitored can be determined based on the total amount of all the above drugs and the total amount of valuable drugs.
  • the ratio of precious drugs may be the ratio of the total amount of valuable drugs in a single-day prescription to the total price of all drugs prescribed in a single day, that is to say, the ratio of precious drugs satisfies the following formula (3):
  • Proportion of valuable drugs total value of valuable drugs / total amount of drugs of all drugs.
  • the total value of valuable drugs is the cumulative value of the prices of various types of valuable drugs in a single-day prescription, where the price of each type of valuable drugs is the product of the quantity of such types of valuable drugs and the unit price of such types of valuable drugs.
  • the total amount of medicines of all the above medicines is the cumulative value of the prices of various medicines in a single day prescription.
  • S14 Determine whether the medication for the medical unit to be monitored meets the standard according to the target drug ratio and the medication standard threshold corresponding to the medical unit to be monitored.
  • the thresholds for the evaluation indicators of the drug monitoring standards and / or drug evaluation standards of each medical unit can be set in advance, such as the upper limit of the proportion of valuable drugs Upper limit of drug proportion) etc.
  • the upper limit of the proportion of valuable drugs corresponding to the medical unit to be monitored can be set based on the historical drug records of the medical unit to be monitored or the drug use policy, etc.
  • the unit's proportion of valuable drugs, combined with the threshold of the assessment index corresponding to the medical unit to be monitored determines whether the medical unit's medications meet the standard.
  • the proportion of valuable drugs of the medical unit to be monitored is less than or equal to its corresponding upper limit of the proportion of valuable drugs. If the proportion of valuable drugs of the medical unit to be monitored is less than or equal to the corresponding upper limit of the proportion of precious drugs, it can be determined that the medical unit to be monitored meets the standard. If the proportion of precious medicines of the medical unit to be monitored is greater than the corresponding upper limit of the proportion of precious medicines, it can be determined that the medication of the medical unit to be monitored is exceeding the standard, that is, the medical cost of the medical unit to be monitored exceeds the standard.
  • FIG. 2 is another schematic flow chart of the medication monitoring method based on data processing provided by an embodiment of the present application.
  • the medicine monitoring method based on data processing provided in the embodiments of the present application can realize the monitoring of the medication situation of the medical unit to be monitored within a single assessment period.
  • the method can be described by the implementation methods provided in the steps S21 to S26 as follows.
  • the implementation manner of obtaining the medication prescription of the medical unit to be monitored may refer to the implementation manner provided in step S11 in the foregoing embodiment, and details are not described herein again.
  • the medication prescription of the medical unit may further include all medication prescriptions generated by the medical unit to be monitored within a single assessment cycle, wherein the single assessment cycle is greater than one day, such as one week, one Months, quarters, or years, etc., no restrictions here.
  • the single assessment cycle is greater than one day, such as one week, one Months, quarters, or years, etc., no restrictions here.
  • all medication prescriptions generated by the above-mentioned medical unit to be monitored in a single assessment cycle can be illustrated by taking a single assessment cycle prescription as an example.
  • the single assessment cycle prescription of the medical unit may refer to all prescriptions issued in any assessment cycle of the medical unit more than one day, including but not limited to all prescriptions issued by all doctors in all departments of the hospital in a single assessment cycle All prescriptions, all prescriptions issued by all doctors in a department of the hospital in a single assessment cycle, or all prescriptions issued by a doctor in a department of the hospital in a single assessment cycle.
  • the specific conditions indicated in the above single assessment cycle prescriptions are based on the evaluation dimensions of drug monitoring of medical units in actual application scenarios (for example, drug monitoring for medical units, drug monitoring for a department of the medical unit, or A certain doctor in a certain department conducts medication monitoring, etc.), and it is not restricted here.
  • the following will take all prescriptions issued by all doctors in all departments of the hospital in a single assessment cycle as an example for explanation, hereinafter referred to as a single assessment cycle prescription.
  • any prescription included in the single assessment cycle prescription of the medical unit to be monitored here can include the details of the drugs prescribed in the prescription, including but not limited to the name of the drug, the amount of the drug, the method of use of the drug and the use of the drug
  • the number of days can be determined according to the actual application scenario, without limitation.
  • the average daily drug cost based on the prescription of the medical unit to be monitored may also be processed to obtain the average daily drug cost of the medical unit to be monitored within a specified time period, for example, one week, one The average daily drug cost per month, quarter or year.
  • a specified time period for example, one week, one The average daily drug cost per month, quarter or year.
  • the following can be used as an assessment cycle for a week, taking the average daily drug cost of a week as an example for explanation, referred to as the average daily drug cost for prescriptions in a single assessment cycle.
  • the average daily drug cost for a single assessment cycle prescription can meet the following formula (4):
  • the total amount of periodic drugs can be the total amount of all drugs obtained by accumulating the total amount of all drugs included in all prescriptions in a single assessment cycle. The cumulative value of the number of days of use of each drug in all drugs included in the prescription.
  • any single-day medication prescription on any day within a single assessment cycle can be obtained, and any The drug information of each drug included in the single-day medication prescription, where the drug information includes but is not limited to the drug amount and the number of days the drug is used.
  • the daily average daily drug cost of any day of the medical unit to be monitored may refer to the implementation manner corresponding to formula (1) in the foregoing embodiment, and details are not described herein again.
  • the total number of days of drug use in the daily prescription can be determined, and then the waiting period can be determined based on the total number of days of drug use in the daily prescription Monitor the total days of drug use for all drugs included in the single assessment cycle prescription of the medical unit.
  • the total number of days of drug use on any day within a single assessment period of the medical unit to be monitored is the sum of the number of days of drug use of each drug included in any single-day prescription.
  • the cumulative value of the average daily drug cost per day in a single evaluation cycle of the medical unit to be monitored can be determined according to the daily average daily drug cost of each day in the single evaluation cycle.
  • the accumulated value of the average daily drug cost According to the total number of days of drug use in each day of the single assessment cycle, the accumulated value of the total number of days of drug use in the single assessment period of the medical unit to be monitored can be determined.
  • the daily average drug cost of the medical unit to be monitored is determined according to the cumulative value of the above-mentioned average daily daily drug cost and the cumulative value of the above-mentioned total days of drug use.
  • the average daily drug cost of the medical unit to be monitored (that is, the average daily drug cost of the medical unit to be monitored in a single assessment cycle) can satisfy the following formula (5):
  • Average daily drug cost accumulated value of average daily drug cost per day / cumulative value of total days of drug use.
  • the cumulative value of the average daily drug cost in the above formula (5) may be the cumulative average of the daily drug cost of each single-day prescription in the 7 single-day prescriptions within a week Value
  • the accumulated value of the total number of days of drug use in the above formula (5) may be the accumulated value of the total number of days of drug use of each single-day prescription in 7 single-day prescriptions within a week.
  • step S12 for the specific implementation manner of determining the average daily drug cost of a single medicine for various types of medicines of the medical unit to be monitored based on the drug information included in the medical prescription of the medical unit to be monitored, see step S12 in the above embodiment The implementation provided will not be repeated here.
  • the terminal device can also calculate each type of drug in all prescriptions within a single assessment cycle of the medical unit over multiple days The average daily drug cost of a single drug. Based on all the prescriptions within a single assessment cycle of the medical unit to be monitored, the drug information of all types of drugs included in all prescriptions can be obtained.
  • the above drug information includes at least the drug amount and the number of days the drug is used.
  • the total amount of medicines of any kind of medicines and the total number of days of use of medicines of any kind of medicines in all prescriptions in the above single assessment period determine the total amount of drugs for a class of drugs and the total number of days of use of any of the above-mentioned drugs determine the average daily drug cost per drug for any of the above-mentioned drugs to obtain the average daily drug cost for each drug of the above-mentioned types.
  • the calculation of the average daily drug cost of a single drug of any of the above drugs can meet the following formula (6):
  • the total amount of any kind of drugs in the above formula (6) is the single-drug drug obtained by accumulating the price of a certain kind of drugs (in any category for convenience of description) of all the prescriptions of all drugs in a single assessment cycle
  • the total price, the total number of days of use of any type of drug in the above single evaluation cycle is the cumulative value of the number of days of use of the drugs of this type among all prescriptions of all drugs within a single evaluation cycle.
  • each prescription in all prescriptions within a single assessment cycle of the medical unit to be monitored can be determined
  • the average daily drug cost of a single drug of a class of drugs, and then based on the average daily drug cost of a single drug of the above-mentioned types of drugs, can determine the precious drugs in all prescriptions within a single evaluation cycle.
  • step S13 for the specific implementation manner of determining the average daily drug cost of a single medicine for various types of medicines of the medical unit to be monitored based on the drug information included in the medical prescription of the medical unit to be monitored, see step S13 in the above embodiment The implementation provided will not be repeated here.
  • the proportion of valuable drugs may be the ratio of the total value of the valuable drugs in all prescriptions in a single evaluation period to the total price of all the drugs in all prescriptions in a single evaluation period, that is to say, the proportion of valuable drugs satisfies the following formula (7 ):
  • Proportion of valuable drugs total value of valuable drugs / total amount of drugs of all drugs.
  • the total value of valuable drugs is the cumulative value of various types of valuable drugs in all prescriptions within a single evaluation period, where the price of each type of valuable drugs is the number of such valuable drugs and the value of such valuable drugs The product of unit prices.
  • the total amount of medicines of all the above-mentioned medicines is the cumulative value of the prices of all kinds of medicines in all prescriptions in a single assessment period.
  • S25 Determine the upper limit of the target drug ratio of the medical unit to be monitored according to the unit attribute information of the medical unit to be monitored.
  • S26 Determine whether the medication used by the medical unit to be monitored meets the standard according to the target drug ratio of the medical unit to be monitored and the target upper limit of the target drug ratio of the medical unit to be monitored.
  • step S14 for the specific implementation manner of determining whether the medication of the medical unit to be monitored meets the standard according to the proportion of valuable drugs of the medical unit to be monitored and the medication standard threshold corresponding to the medical unit to be monitored, refer to step S14 in the foregoing embodiment The implementation provided will not be repeated here.
  • the evaluation index thresholds of the drug monitoring standards and / or drug evaluation standards of each medical unit may also be determined based on the unit attribute information of each medical unit, For example, the upper limit of the proportion of valuable drugs.
  • the unit attribute information of the medical unit to be monitored includes one or more of the unit type, the region where the unit is located, the city where the unit is located, the unit drug supply channel, and the number of patients of the unit, which can be determined according to the actual application scenario. There are no restrictions here. For example, based on different medical units associated with parameters such as different regions, different cities, different drug supply channels, or different patient flows, the evaluation thresholds for drug monitoring may vary.
  • the upper limit of the proportion of valuable drugs can be set higher, namely The threshold of the assessment index of the corresponding medication monitoring standard can be set to a higher assessment index.
  • the upper limit of the proportion of valuable drugs can be set lower, that is, their corresponding The threshold of the assessment index of the monitoring standard of medication can be set to a lower assessment index.
  • the medical unit based on the above-mentioned determined ratio of valuable drugs of the medical unit to be monitored, combined with the assessment index threshold determined based on the unit attribute information of the medical unit to be monitored (that is, the upper limit of the proportion of valuable drugs), the medical unit ’s Whether the medication meets the standard, in other words, whether the proportion of valuable drugs in the medical unit to be monitored is less than or equal to its corresponding upper limit of the proportion of precious drugs. If the proportion of valuable drugs of the medical unit to be monitored is less than or equal to the upper limit of the corresponding proportion of precious drugs, it can be determined that the medication of the medical unit to be monitored is up to the standard, otherwise the medication of the medical unit is over the standard.
  • the drug monitoring of the medical unit to be monitored may also be comprehensively evaluated based on the proportion of precious drugs and the daily average drug cost of the medical unit to be monitored. For example, only when the proportion of valuable drugs and the average daily drug cost meet the standard, the drug cost of the medical unit to be monitored will not exceed the standard.
  • the evaluation index thresholds of the drug evaluation standards of each medical unit can be set based on the characteristics of each medical unit, such as the upper limit of the daily average drug cost, Or the average daily drug cost threshold. For example, based on different medical units associated with parameters such as different regions, different cities, different drug supply channels, or different patient flows, the evaluation index thresholds for drug evaluation standards may vary.
  • the upper limit of the average daily drug cost can be set higher, namely
  • the threshold of the assessment index of the corresponding medication evaluation standard can be set to a higher assessment index and so on. Furthermore, based on the above-mentioned daily average drug cost of the medical unit to be monitored, combined with the threshold of the assessment index corresponding to the medical unit to determine whether the medical standard of the medical unit meets the standard, in other words, whether the average daily drug cost of the medical unit to be monitored It is lower than or equal to its corresponding daily average drug cost threshold.
  • the average daily drug cost of the medical unit to be monitored reaches the standard, and the proportion of valuable drugs also reaches the standard, it is determined that the medical unit's medication is up to the standard, otherwise, the medical unit to be monitored exceeds the standard.
  • the specifics can be determined according to actual application scenarios, and no limitation is made here.
  • the medical drug monitoring operation modes of various medical units are various, which can not only improve the accuracy of medical drug monitoring of medical units, but also improve the reliability of medical drug monitoring of medical units, and can also enhance the medical treatment of medical units.
  • the operation flexibility of the unit's medication monitoring is more applicable.
  • FIG. 3 is a schematic structural diagram of an embodiment of a medication monitoring device based on data processing provided by an embodiment of the present application.
  • the medication monitoring device based on data processing provided by the embodiments of the present application includes:
  • the data obtaining unit 31 is used to obtain the medication prescription of the medical unit to be monitored.
  • the medicine information processing unit 32 is used to obtain the medicine information of the medicines included in the medicine prescription obtained by the data obtaining unit 31, and determine the single-medium daily medicines of the medicines according to the medicine information of the medicines cost.
  • the above-mentioned drug information processing unit 32 is also used to determine the target drug in the above-mentioned drug prescription based on the average daily drug cost of the above-mentioned drugs, and to determine the above-mentioned target drug in the above-mentioned drug prescription based on the drug information of the above-mentioned drugs Target drug ratio.
  • the medication evaluation unit 33 is configured to determine whether the medication of the medical unit to be monitored meets the standard based on the target drug ratio determined by the drug information processing unit 32 and the medication standard threshold corresponding to the medical unit to be monitored.
  • the data acquisition unit 31 is used to:
  • the medicine prescription of the medical unit to be monitored includes all the prescriptions of the medicine of the medical unit to be monitored in a single assessment cycle, and the cycle duration of the single assessment cycle includes one or more days.
  • the above-mentioned drug information processing unit 32 is used to:
  • the above medicine information at least includes the medicine amount and the number of days of medicine use;
  • the drug information of the above-mentioned types of drugs determine the total amount of drugs of any type of drugs in the above-mentioned prescriptions and the total number of days of drug use of any of the above types of drugs;
  • the average daily drug cost of any of the above-mentioned drugs meets:
  • the average daily drug cost of a single drug the total drug amount of any type of drug / the total number of days of drug use of any type of drug.
  • the above-mentioned drug information processing unit 32 is used to:
  • the medicine with a threshold is determined as the target medicine in the above medicine prescription.
  • the above-mentioned drug information processing unit 32 is used to:
  • the above target drug ratio meets:
  • Target drug ratio total target drug / total drug for all drugs.
  • the above-mentioned medicine information processing unit 32 is further used to:
  • the unit attribute information of the medical unit to be monitored includes one or more of the unit type, the region where the unit is located, the city where the unit is located, the drug supply channel of the unit, and the number of patients of the unit.
  • the above-mentioned medication evaluation unit 33 is used to:
  • the target drug ratio of the medical unit to be monitored determined by the drug information processing unit 32 is less than or equal to the upper limit of the target drug ratio, it is determined that the drug of the medical unit to be monitored meets the standard;
  • the target drug ratio of the medical unit to be monitored is greater than the upper limit of the target drug ratio, it is determined that the medical unit to be monitored does not meet the standard.
  • the above-mentioned data processing-based medication monitoring device may execute the implementation manners provided by the above steps in FIGS. 1 to 2 through various built-in functional modules.
  • the above medication monitoring device based on data processing may be the terminal device described in each of the foregoing embodiments, and is not limited herein.
  • the embodiments of the present application can not only improve the accuracy of the medication monitoring of the medical unit and the reliability of the medication monitoring of the medical unit, but also enhance the operational flexibility of the medication monitoring of the medical unit and have greater applicability.
  • FIG. 4 is a schematic structural diagram of an embodiment of a terminal device provided by an embodiment of the present application.
  • the terminal device in this embodiment may include: one or more processors 401 and a memory 402.
  • the processor 401 and the memory 402 are connected via a bus 403.
  • the memory 402 is used to store a computer program, and the computer program includes program instructions, and the processor 401 is used to execute the program instructions stored in the memory 402.
  • the processor 401 is configured to call the program instruction to perform the following operations:
  • the medication standard threshold corresponding to the medical unit to be monitored it is determined whether the medication of the medical unit to be monitored meets the standard.
  • the foregoing processor 401 is configured to:
  • the medicine prescription of the medical unit to be monitored includes all the medicine prescriptions of the medical unit to be monitored in a single evaluation cycle, and the cycle duration of the single evaluation cycle includes one or more days.
  • the foregoing processor 401 is configured to:
  • the above medicine information at least includes the medicine amount and the number of days of medicine use;
  • the drug information of the above-mentioned types of drugs determine the total amount of drugs of any type of drugs in the above-mentioned prescriptions and the total number of days of drug use of any of the above types of drugs;
  • the average daily drug cost of any of the above-mentioned drugs meets:
  • the average daily drug cost of a single drug the total drug amount of any type of drug / the total number of days of drug use of any type of drug.
  • the foregoing processor 401 is configured to:
  • the medicine with a threshold is determined as the target medicine in the above medicine prescription.
  • the foregoing processor 401 is configured to:
  • the above target drug ratio meets:
  • Target drug ratio total target drug / total drug for all drugs.
  • the foregoing processor 401 is further used to:
  • the unit attribute information of the medical unit to be monitored includes one or more of the unit type, the region where the unit is located, the city where the unit is located, the drug supply channel of the unit, and the number of patients of the unit.
  • the foregoing processor 401 is configured to:
  • the target drug ratio of the medical unit to be monitored is less than or equal to the upper limit of the target drug ratio, it is determined that the drug of the medical unit to be monitored meets the standard
  • the target drug ratio of the medical unit to be monitored is greater than the upper limit of the target drug ratio, it is determined that the medication of the medical unit to be monitored does not meet the standard.
  • the processor 401 may be a central processing unit (CPU), and the processor may also be other general-purpose processors, digital signal processors (DSPs), and dedicated integrations. Circuit (application specific integrated circuit, ASIC), ready-made programmable gate array (field-programmable gate array, FPGA) or other programmable logic devices, discrete gate or transistor logic devices, discrete hardware components, etc.
  • the general-purpose processor may be a microprocessor or the processor may be any conventional processor or the like.
  • the memory 402 may include a read-only memory and a random access memory, and provide instructions and data to the processor 401. A portion of the memory 402 may also include non-volatile random access memory. For example, the memory 402 may also store device type information.
  • the above-mentioned terminal device may execute the implementation manners provided by the steps in FIG. 1 to FIG. 2 through the function modules of the built-in processor 401.
  • the above-mentioned terminal device may execute the implementation manners provided by the steps in FIG. 1 to FIG. 2 through the function modules of the built-in processor 401.
  • the implementation manners provided by the above steps And will not be repeated here.
  • the embodiments of the present application can realize various operation modes of medication monitoring for each medical unit, which can not only improve the accuracy of medication monitoring of medical units, improve the reliability of medication monitoring of medical units, but also enhance the medication of medical units.
  • the operation flexibility of monitoring is more applicable.
  • Embodiments of the present application also provide a computer-readable storage medium that stores a computer program, and the computer program includes program instructions, which are executed by a processor to implement the steps in FIGS. 1 to 2.
  • the computer program includes program instructions, which are executed by a processor to implement the steps in FIGS. 1 to 2.
  • the foregoing computer-readable storage medium may be the data processing-based medication monitoring device provided in any of the foregoing embodiments or the internal storage unit of the foregoing terminal device, such as a hard disk or memory of an electronic device.
  • the computer-readable storage medium may also be an external storage device of the electronic device, such as a plug-in hard disk equipped on the electronic device, a smart memory card (smart media card, SMC), a secure digital (SD) card, Flash card (flash card), etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

一种基于数据处理的用药监控方法及装置，该方法包括：获取待监控医疗单位的用药处方(S11)；获取上述用药处方中所包括的各类药品的药品信息，并根据各类药品的药品信息确定各类药品的单药日均药品费用(S12)；根据各类药品的单药日均药品费用确定出上述用药处方中的目标药品，并根据各类药品的药品信息确定出目标药品在上述用药处方的目标药品比例(S13)；根据上述目标药品比例和待监控医疗单位对应的用药标准阈值，确定待监控医疗单位的用药是否达标(14)。采用所述方法，可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，适用性强。

Description

基于数据处理的用药监控方法及装置
本申请要求于2018年10月22日提交中国专利局、申请号为201811234422.X、申请名称为“基于数据处理的用药监控方法及装置”的中国专利申请的优先权，其全部内容通过引用结合在本申请中。
技术领域
本申请涉及医疗技术领域，尤其涉及一种基于数据处理的用药监控方法及装置。
背景技术
当前为了规范各个医疗单位的用药标准，规避大处方行为，从而避免药品的滥用和浪费，起到合理施治的目的，各式各样的用药监控机制应运而生。各式各样的用药监控机制用于对各个医疗单位进行用药监控，包括但不限于各个医院、各个医院的科室、各个诊所乃至各个医师等医疗单位(或者医疗单位的代表)进行用药监控。
现有技术中，对于各个医疗单位的用药标准的评价主要是采用次均处方标准，也就是将每次计算的处方平均费用(简称次均处方费用)作为各个医疗单位的用药评价标准。其中，上述次均处方费用的用药评价标准是采用处方总额除以处方数量的方式来计算得到。现有技术采用次均处方费用作为各个医疗单位的用药评价标准导致各个医疗单位为了规避大处方行为被考核，通常会采用缩减处方天数来减低次均处方费用，或者通过分解处方的方式将单个处方总额较大的大处方分解为多个单个处方总额较小的小处方等方式来降低次均处方费用，从而规避大处方的监控。现有技术的实现方式使得各个医疗单位的用药监控的漏洞较大，对各个医疗单位的用药监控准确率低，适用性差。
发明内容
本申请实施例提供一种基于数据处理的用药监控方法及装置，操作简单，可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，适用性更强。
第一方面，本申请实施例提供了一种基于数据处理的用药监控方法，该方法包括：
获取待监控医疗单位的用药处方；
获取上述用药处方中所包括的各类药品的药品信息，并根据上述各类药品的药品信息确定上述各类药品的单药日均药品费用；
根据上述各类药品的单药日均药品费用确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定出上述目标药品在上述用药处方的目标药品比例；
根据上述目标药品比例和上述待监控医疗单位对应的用药标准阈值，确定上述待监控医疗单位的用药是否达标。
第二方面，本申请实施例提供了一种基于数据处理的用药监控装置，该用药监控装置包括：
数据获取单元，用于获取待监控医疗单位的用药处方；
药品信息处理单元，用于获取上述数据获取单元获取的上述用药处方中所包括的各类药品的药品信息，并根据上述各类药品的药品信息确定上述各类药品的单药日均药品费用；
上述药品信息处理单元，还用于根据上述各类药品的单药日均药品费用确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定出上述目标药品在上述用药处方的目标药品比例；
用药评价单元，用于根据上述药品信息处理单元确定的上述目标药品比例和上述待监控医疗单位对应的用药标准阈值，确定上述待监控医疗单位的用药是否达标。
第三方面，本申请实施例提供了一种终端设备，该终端设备包括处理器和存储器，该处理器和存储器相互连接。该存储器用于存储支持该终端设备执行上述第一方面和/或第一方面任一种可能的实现方式提供的方法的计算机程序，该计算机程序包括程序指令，该处理器被配置用于调用上述程序指令，执行上述第一方面和/或第一方面任一种可能的实施方式所提供的方法。
第四方面，本申请实施例提供了一种计算机可读存储介质，该计算机可读存储介质存储有计算机程序，该计算机程序包括程序指令，该程序指令当被处理器执行时使该处理器执行上述第一方面和/或第一方面任一种可能的实施方式所提供的方法。
基于本申请实施例提供的方法实现对各医疗单位的用药监控操作简单，可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，适用性更强。
附图说明
图1是本申请实施例提供的基于数据处理的用药监控方法的一流程示意图；
图2是本申请实施例提供的基于数据处理的用药监控方法的另一流程示意图；
图3是本申请实施例提供的基于数据处理的用药监控装置的实施例结构示意图；
图4是本申请实施例提供的终端设备的实施例结构示意图。
具体实施方式
目前，各个地区的贵重药品的确定是将最小包装单位(例如一瓶、一包、一盒或者一袋等)的单价药品超过某一个阈值的药品确定为贵重药品。然而，这种方法确定贵重药品没有考虑最小包装单位的单价药品的使用天数问题，因此可能存在的弊端是单价相同的药品或者某个低价药品或者某个高价药品由于使用天数不同，导致药品的单价较高但是单日均价较低的倒挂情况。比如某药品单盒售价为300元，按照目前各地区的贵重药品判定方式判定为贵重药品；该贵重药品一盒可使用30天，也就是该药品的单日均价是10元/天。另外一个药品单盒售价为120元，按照目前各地区的贵重药品判定方式判定为非贵重药品；该药品一盒可以用3天，也就是该药品的单日均价是40元/天。由此可见，按照目前各地区的贵重药品的判定方式判定的非贵重药品的单日均价超出了贵重药品的单日均价，显而 易见，该判定方式对贵重药品的评估准确率低，使得贵重药品的考核漏洞较大。
在一些可行的实施方式中，本申请实施例提供的目标药品可为贵重药品，这里贵重药品的确定方式与上述目前各地区的贵重药品的确定方式不同。这里，贵重药品可为用药处方中所包括的各类药品中的单药日均药品费用较高且在该用药处方所包括的各类药品的单药日均药品费用中排序靠前的药品。下面将以贵重药品为例，结合本申请实施例提供的基于数据处理的药品费用超标预警方法进行描述。对应的，目标药品比例可以贵重药品比例为例进行说明，下面不再赘述。
本申请实施例提供了一种基于数据处理的用药监控方法，可基于各个医院、各个医院的科室、各个诊所乃至各个医师等医疗单位(或者医疗单位的代表(或称团队))的贵重药品比例来评价各个医疗单位(包括医院、科室、诊所或者医师)的用药是否达标(或称合理)。为方便描述，上述各个医院、各个医院的科室、各个诊所乃至各个医师等等医疗单位或者医疗单位的代表所表示的考核维度将以医疗单位的这个考核维度为例进行说明，下面不再赘述。
本申请实施例所提供的用药处方可包括各个医疗单位的各个医师针对各个病患的病症所开具的处方，或称各个医师针对各个病患的病症所开具的药方，或称处方笺等，在此不做限制。为方便描述，下面将以处方为例进行说明。通常来讲，各个医疗单位的各个医师所开具的处方中可包括但不限于处方开具时间、处方编号、科室编号、病患个人信息、药品详情以及医师签字，具体可根据实际应用场景确定，在此不做限制。换句话说，无论是单个处方总额较大的大处方，还是单个处方总额较小的小处方，或者其他更多表现形式的处方，每个处方中均会有医疗单位开具的药品详情，包括但不限于药品名称、药品金额、药品使用方式以及药品使用天数等。基于各个处方中所包括的药品详情可确定出单药日均药品费用较高且排序靠前的药品作为贵重药品，进而可基于贵重药品的费用在所有处方中的药品总费用的比例(即贵重药品比例)来确定用药是否合理。因此无论是大处方还是小处方还是其他，均离不开药品详情。因此，基于各个医疗单位的贵重药品比例实现对各个医疗单位的用药标准的评价时利用了各类药品对应的日均药品费用(即单药日均药品费用)，同时也考虑到各类药品的费用占比情况，操作简单并且可更好地、更加全面地覆盖到对医疗单位的各个处方的用药监控。同时基于医疗单位的贵重药品比例实现对各个医疗单位的用药监控更加准确到位，从而可提高对各个医疗单位的用药监控的准确率，适用性更高。
在一些可行的实施方式中，基于医疗单位的贵重药品比例对医疗单位进行用药监控时可每天对医疗单元的用药情况进行监控，进而可每天结算医疗单位的贵重药品比例，基于每天的贵重药品比例对医疗单位的用药情况进行监控。可选的，基于每天的贵重药品比例对医疗单位进行用药监控的同时，也可基于累计多天的用药监控情况对医疗单位进行用药情况的综合评价等，例如一个星期、一个月、一个季度或者一年等，具体可根据实际应用场景确定，在此不做限制。为方便描述，下面将以任一日(为方便描述下面将以单日为例 进行说明)的各类药品对应的日均药品费用以及贵重药品比例的计算，进而可基于每天的贵重药品比例和/或日均药品费用对医疗单位的用药情况进行评价为例，对本申请实施例提供的基于数据处理的用药监控方法进行描述。
本申请实施例提供的基于数据处理的用药监控方法可由药品监督管理局、卫生委员会、卫生与健康委员会以及医疗理赔单位等用药监控单位所关联的终端设备执行，例如上述用药监控单位用于对各个医疗单位进行用药监控的客户端和/或人机交互设备等，在此不做限制。为方便描述，下面将以终端设备为例进行说明。
实施例一：
参见图1，图1是本申请实施例提供的基于数据处理的用药监控方法的一流程示意图。本申请实施例提供的基于数据处理的用药监控方法，可通过如下步骤S11至S14中各个步骤所提供的实现方式进行说明。
S11，获取待监控医疗单位的用药处方。
在一些可行的实施方式中，上述待监控医疗单位可为用药监控单位所监控的任一医疗单位，具体可根据实际应用场景确定，在此不做限制。换句话说，任一医疗单位都可能被用药监控单位作为监控对象，因此被选中的监控对象则可为待监控医疗单位。为方便描述，下面将以待监控医疗单位为例进行说明。
在一些可行的实施方式中，上述医疗单位的用药处方可包括待监控医疗单位在单日时间内所产生的所有用药处方。为方便描述，上述待监控医疗单位在单日时间内所产生的所有用药处方可以单日处方为例进行说明。上述医疗单位的单日处方可以是指医疗单位的任一日所开具的所有处方，包括但不限于单日时间内医院的所有科室所有医师所开具的所有处方、单日时间内医院的某一个科室的所有医师所开具的所有处方，或者单日时间内医院的某一个科室的某一个医师所开具的所有处方中的任一种情况。其中，上述单日处方所表示的具体情况根据实际应用场景中对医疗单位进行用药监控的考核维度(例如针对医疗单位进行用药监控、针对医疗单位的某一个科室进行用药监控或者针对医疗单位的某一个科室的某一个医师进行用药监控等)确定，在此不做限制。为方便描述，下面将以单日时间内医院的所有科室所有医师所开具的所有处方为例进行说明，以下简称单日处方。
在一些可行的实施方式中，终端设备可与待监控医疗单位的数据系统对接，获取待监控医疗单位的数据系统准入资格，进而可基于待监控医疗单位的数据系统准入资格从待监控医疗单位的数据系统中获取待监控医疗单位的处方，例如待监控医疗单位的单日处方等。可选的，终端设备也可基于待监控医疗单位所提供了医疗理赔数据，从医疗理赔数据中筛选得到医疗单位的单日处方等处方数据。可选的，终端设备也可基于大数据分析，从各个医疗单位的病患就诊记录中筛选得到待监控医疗单位的单日处方等处方数据，等等。终端设备可基于上述数据获取方式之外的任一数据获取路径获取得到待监控医疗单位的单日处方，具体可根据实际应用场景确定，在此不做限制。
可以理解，这里待监控医疗单位的单日处方中任一处方上均可包括该处方中所开药品的药品详情，包括但不限于药品名称、药品金额，药品使用方式(或称药品服用方式等)以及药品使用天数，具体可根据实际应用场景确定，在此不做限制。
S12，获取上述用药处方中所包括的各类药品的药品信息，并根据上述各类药品的药品信息确定上述各类药品的单药日均药品费用。
在一些可行的实施方式中，基于待监控医疗单位的单日处方可以确定待监控医疗单位的单日处方中所有处方所包括各药品的药品信息，其中，任一药品的药品信息中包括但不限于药品金额和药品使用天数。基于上述待监控医疗单位的单日处方中所有处方所包括的各药品的药品信息可确定待监控医疗单位的单日处方中所包括的药品总数、药品总额以及药品使用总天数等等。其中，上述任一药品的药品金额为任一药品的单价和数量相乘得到单个药品的价格。上述药品总数表示单日处方中所有处方中所使用的药品累加之后的药品总数。上述药品总额为基于单日处方中所包括的每个药品的单价和数量相乘得到单个药品的药品金额之后，再将单日处方中所包括的所有药品的药品金额进行累加得到所有药品的药品总价(即药品总额)。上述药品使用总天数为单日处方中所有药品中每个药品的药品使用天数的累加值。待监控医疗单位的单日处方的日均药品费用表示待监控医疗单位单日处方中所包括的所有药品的平均费用，这里可以日均药品费用进行说明。其中，上述待监控医疗单位的单日处方的日均药品费用可基于如下公式(1)计算得到：
公式(1)：日均药品费用＝药品总额/药品使用总天数。
其中，在上述公式(1)中药品总额即单日处方中所有药品的药品金额累加得到的所有药品的总价，上述药品使用总天数即单日处方中所有药品中每个药品的药品使用天数的累加值。为方便描述，下面简称医疗单位的日均药品费用。
在一些可行的实施方式中，基于上述医疗单位的日均药品费用的计算方式相同的原理，终端设备还可计算得到医疗单位的单日处方中每类药品的日均药品费用。其中，任一类药品的日均药品费用下面可以单药日均药品费用为例进行说明。基于上述待监控医疗单位的单日处方，可获取所有用药处方中所包括的各类药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数。根据上述单日处方中各类药品的药品信息确定出上述单日处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数，根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用。其中，上述任一类药品的单药日均药品费用的计算可满足如下公式(2)：
公式(2)：单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
其中，在上述公式(2)中任一类药品总额即单日处方的所有药品中某一个种类(为方便描述以任一类进行描述)的药品的价格累加得到的单药药品总价，上述任一类药品使用总天数即单日处方的所有药品中该种类药品药品的使用天数的累加值。
基于上述公式(2)所提供的实现方式，结合待监控单位的单日处方中所包括的各类药品的药品信息可确定待监控医疗单位的单日处方中各类药品的单药日均药品费用，进而可基于上述各类药品的单药日均药品费用确定出单日处方中的贵重药品。
S13，根据上述各类药品的单药日均药品费用确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定出上述目标药品在上述用药处方的目标药品比例。
在一些可行的实施方式中，根据上述步骤S12所确定的各类药品的单药日均药品费用，可确定出待监控单位的单日处方对应的单药日均药品费用阈值，并将上述各类药品中单药日均药品费用大于或者等于上述单药日均药品费用阈值的药品确定为待监控医疗单位的单日处方中的贵重药品。这里，贵重药品是指单药日均药品费用在单日处方的所有药品的单药日均药品费用中费用较高且单药日均药品费用大于或者等于单药日均药品费用阈值的药品。换句话说，基于单日处方中各类药品的单药日均药品费用可将各类药品的单药日均药品费用按照从高到低的顺序进行排序，进而可从单药日均药品费用排序靠前的一部分(例如20％)药品中单药日均药品费用最低的一个确定为单药日均药品费用阈值，此时这部分(即20％)的药品中各药品的单药日均药品费用均大于或者等于单药日均药品费用阈值，进而可将这部分(即20％)的药品确定为贵重药品。比如，在单日处方的所有药品中，根据各类药品的单药日均药品费用确定单药日均药品费用为x元/天(即单药日均药品费用阈值)，例如11元/天的药品则为贵重药品。换句话说，就是待监控医疗单位的单日处方中所包括的所有药品中有20％的药品是单药日均药品费用大于或者等于11元/天的药品，这部分药品则为贵重药品。
在一些可行的实施方式中，根据上述各类药品的药品信息可确定出上述用药处方中所有药品的药品总额，以及上述用药处方中所包括的上述贵重药品的贵重药品总额。根据上述所有药品的药品总额和上述贵重药品总额可确定出待监控医疗单位的单日处方中的贵重药品比例。这里，贵重药品比例可以是单日处方中贵重药品的药品总额在单日处方的所有药品的药品总价格中的比例，也就是说贵重药品比例满足如下公式(3)：
公式(3)：贵重药品比例＝贵重药品总额/所有药品的药品总额。
在上述公式(3)中，贵重药品总额为单日处方中各类贵重药品的价格累计值，其中，每类贵重药品的价格为该类贵重药品的数量与该类贵重药品的单价的乘积。上述所有药品的药品总额为单日处方中各类药品的价格累加值。
S14，根据上述目标药品比例和上述待监控医疗单位对应的用药标准阈值，确定上述待监控医疗单位的用药是否达标。
在一些可行的实施方式中，针对不同医疗单位进行用药监控时，可预先设定各个医疗单位的用药监控标准和/或用药评价标准的考核指标阈值，例如贵重药品比例的达标上限(或称贵重药品比例上限)等。例如，针对待监控医疗单位进行用药监控时，可基于待监控医疗单位的历史用药记录或者药品使用政策等信息设定待监控医疗单位对应的贵重药品 比例上限，进而可基于上述确定的待监控医疗单位的贵重药品比例，结合该待监控医疗单位对应的考核指标阈值(即贵重药品比例上限)确定该医疗单位的用药是否达标。换句话说，就是该待监控医疗单位的贵重药品比例是否小于或者等于其对应的贵重药品比例上限。若该待监控医疗单位的贵重药品比例小于或者等于其对应的贵重药品比例上限，则可确定待监控医疗单位的用药是达标的。若待监控医疗单位的贵重药品比例大于其对应的贵重药品比例上限，则可确定待监控医疗单位的用药是超标的，即待监控医疗单位的用药费用超标。
基于本申请实施例提供的方法实现对各医疗单位的用药监控操作简单，可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，适用性更强。
实施例二：
参见图2，图2是本申请实施例提供的基于数据处理的用药监控方法的另一流程示意图。本申请实施例提供的基于数据处理的用药监控方法可实现对待监控医疗单位在单个考核周期内的用药情况进行监控，该方法可通过如下步骤S21至S26中各个步骤所提供的实现方式进行说明。
S21，获取待监控医疗单位的用药处方。
在一些可行的实施方式中，上述获取待监控医疗单位的用药处方的实现方式可参见上述实施例中步骤S11所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，上述医疗单位的用药处方还可包括待监控医疗单位在单个考核周期内产生的所有用药处方，其中上述单个考核周期大于一日，例如一个星期、一个月、一个季度或者一年等，在此不做限制。为方便描述，上述待监控医疗单位在单个考核周期内所产生的所有用药处方可以单考核周期处方为例进行说明。
可选的，上述医疗单位的单考核周期处方可以是指医疗单位的多于一日的任一考核周期内所开具的所有处方，包括但不限于单个考核周期内医院的所有科室所有医师所开具的所有处方、单个考核周期内医院的某一个科室的所有医师所开具的所有处方，或者单个考核周期内医院的某一个科室的某一个医师所开具的所有处方中的任一种情况。其中，上述单考核周期处方所表示的具体情况根据实际应用场景中对医疗单位进行用药监控的考核维度(例如针对医疗单位进行用药监控、针对医疗单位的某一个科室进行用药监控或者针对医疗单位的某一个科室的某一个医师进行用药监控等)确定，在此不做限制。为方便描述，下面将以单个考核周期内医院的所有科室所有医师所开具的所有处方为例进行说明，以下简称单考核周期处方。
可以理解，这里待监控医疗单位的单考核周期处方中所包括的任一处方上均可包括该处方中所开药品的药品详情，包括但不限于药品名称、药品金额，药品使用方式以及药品使用天数，具体可根据实际应用场景确定，在此不做限制。
S22，获取上述用药处方中所包括的药品信息，并根据上述药品信息确定所述待监控医 疗单位的日均药品费用。
在一些可行的实施方式中，上述基于待监控医疗单位的用药处方所包括的药品信息确定待监控医疗单位的日均药品费用的具体实现方式可参见上述实施例中步骤S12所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，基于上述待监控医疗单位的用药处方的日均药品费用还可处理得到指定时间段内待监控医疗单位的日均药品费用，例如，一个星期，一个月，一个季度或者一年的日均药品费用等。为方便描述，下面可以一个星期作为一个考核周期，以一个星期的日均药品费用为例进行说明，简称单考核周期处方的日均药品费用。
可选的，单考核周期处方的日均药品费用可满足如下公式(4):
公式(4)：日均药品费用＝周期药品总额/周期药品使用总天数。
其中，在上述公式(4)中周期药品总额可以是单个考核周期内的所有处方中所包括的所有药品的药品金额累加得到的所有药品的总金额，上述周期药品使用总天数可以是单考核周期处方所包括的所有药品中每个药品的药品使用天数的累加值。
可选的，在一些可行的实施方式中，基于待监控医疗单位的单考核周期处方中所包括的药品信息，可获取单个考核周期内任一日的任一单日用药处方，并获取任一单日用药处方中所包括的各药品的药品信息，其中药品信息中包括但不限于药品金额和药品使用天数。根据任一单日用药处方所包括的各药品的药品金额和药品使用天数确定待监控医疗单位任一日的单日日均药品费用。其中，上述待监控医疗单位的任一日的单日日均药品费用可参见上述实施例中公式(1)对应的实现方式，在此不再赘述。此外，基于待监控医疗单位在单个考核周期内每日处方中所包括的各药品的药品使用天数可确定每日处方中的药品使用总天数，进而可基于每日处方的药品使用总天数确定待监控医疗单位的单考核周期处方中所包括的所有药品的药品使用总天数。其中，待监控医疗单位在单个考核周期内的任一日的药品使用总天数为任一单日处方中所包括的各药品的药品使用天数的总和。根据上述待监控医疗单位在单个考核周期内各日的单日日均药品费用和药品使用总天数可确定待监控医疗单位在单个考核周期内的日均药品费用。
在一些可行的实施方式中，根据上述单个考核周期内各日的单日日均药品费用可确定待监控医疗单位在单个考核周期的单日日均药品费用的累加值，为方便描述可简称单日日均药品费用累加值。根据上述单个考核周期内各日的药品使用总天数可确定待监控医疗单位在单个考核周期内的药品使用总天数的累加值，为方便描述可简称药品使用总天数累加值。根据上述单日日均药品费用累加值和上述药品使用总天数累加值确定待监控医疗单位的日均药品费用。
这里，待监控医疗单位的日均药品费用(即待监控医疗单位在单个考核周期内的日均药品费用)可满足如下公式(5):
公式(5)：日均药品费用＝单日日均药品费用累加值/药品使用总天数累加值。
假设，这里单个考核周期为一个星期，则在上述公式(5)中的单日日均药品费用累加值可以是一个星期内的7个单日处方中各个单日处方的日均药品费用的累加值，上述公式(5)中的药品使用总天数累加值可以是一个星期内的7个单日处方中各个单日处方的药品使用总天数的累加值。
S23，获取上述用药处方中所包括的各类药品的药品信息，并根据上述各类药品的药品信息确定上述各类药品的单药日均药品费用。
在一些可行的实施方式中，上述基于待监控医疗单位的用药处方所包括的药品信息确定待监控医疗单位的各类药品的单药日均药品费用的具体实现方式可参见上述实施例中步骤S12所提供的实现方式，在此不再赘述。
进一步的，在一些可行的实施方式中，基于上述医疗单位的日均药品费用的计算方式相同的原理，终端设备还可计算得到医疗单位的多日的单个考核周期内的所有处方中每类药品的单药日均药品费用。基于上述待监控医疗单位的单个考核周期内的所有处方，可获取所有处方中所包括的各类药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数。根据上述单个考核周期内的所有处方中各类药品的药品信息确定出上述单个考核周期内的所有处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数，根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用。其中，上述任一类药品的单药日均药品费用的计算可满足如下公式(6)：
公式(6)：单药日均药品费用＝单个考核周期内任一类药品的药品总额/单个考核周期内任一类药品的药品使用总天数。
其中，在上述公式(6)中任一类药品总额即单个考核周期内的所有处方的所有药品中某一个种类(为方便描述以任一类进行描述)的药品的价格累加得到的单药药品总价，上述单个考核周期内任一类药品使用总天数即单个考核周期内的所有处方的所有药品中该种类药品药品的使用天数的累加值。
基于上述公式(6)所提供的实现方式，结合待监控单位的单个考核周期内的所有处方中所包括的各类药品的药品信息可确定待监控医疗单位的单个考核周期内的所有处方中各类药品的单药日均药品费用，进而可基于上述各类药品的单药日均药品费用确定出单个考核周期内的所有处方中的贵重药品。
S24，根据上述各类药品的单药日均药品费用确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定出上述目标药品在上述用药处方的目标药品比例。
在一些可行的实施方式中，上述基于待监控医疗单位的用药处方所包括的药品信息确定待监控医疗单位的各类药品的单药日均药品费用的具体实现方式可参见上述实施例中步骤S13所提供的实现方式，在此不再赘述。
这里，贵重药品比例可以是单个考核周期内的所有处方中贵重药品的药品总额在单个 考核周期内的所有处方的所有药品的药品总价格中的比例，也就是说贵重药品比例满足如下公式(7)：
公式(7)：贵重药品比例＝贵重药品总额/所有药品的药品总额。
在上述公式(7)中，贵重药品总额为单个考核周期内的所有处方中各类贵重药品的价格累计值，其中，每类贵重药品的价格为该类贵重药品的数量与该类贵重药品的单价的乘积。上述所有药品的药品总额为单个考核周期内的所有处方中各类药品的价格累加值。
S25，根据所述待监控医疗单位的单位属性信息确定所述待监控医疗单位的目标药品比例上限。
S26，根据上述待监控医疗单位的目标药品比例和上述确定的待监控医疗单位的目标药品比例上限，确定待监控医疗单位的用药是否达标。
在一些可行的实施方式中，上述根据待监控医疗单位的贵重药品比例，和待监控医疗单位对应的用药标准阈值确定待监控医疗单位的用药是否达标的具体实现方式可参见上述实施例中步骤S14所提供的实现方式，在此不再赘述。
可选的，在一些可行的实施方式中，针对不同医疗单位进行用药监控时，还可基于各个医疗单位的单位属性信息确定各个医疗单位的用药监控标准和/或用药评价标准的考核指标阈值，例如贵重药品比例的达标上限等。其中，上述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种，具体可根据实际应用场景确定，在此不做限制。例如，基于不同地域、不同城市、不同药品供应渠道或者不同病患流动量等参数所关联的不同医疗单元，用药监控的考核指标阈值可不尽相同。例如，对于物价较高的城市所关联的医疗单位或者药品供应渠道所带来的药品成本价较高所关联的医疗单元，则可将其贵重药品比例的达标上限可设置得较高一些，即其对应的用药监控标准的考核指标阈值则可设定为较高的考核指标等。对于物价较低的城市所关联的医疗单位或者药品供应渠道所带来的药品成本价较低所关联的医疗单元，则可将其贵重药品比例的达标上限可设置得较低一些，即其对应的用药监控标准的考核指标阈值则可设定为较低的考核指标等。具体可根据实际应用场景确定，在此不做限制。
在一些可行的实施方式中，基于上述确定的待监控医疗单位的贵重药品比例，结合基于待监控医疗单位的单位属性信息所确定的考核指标阈值(即贵重药品比例上限)可确定该医疗单位的用药是否达标，换句话说，就是待监控医疗单位的贵重药品比例是否小于或者等于其对应的贵重药品比例上限。若待监控医疗单位的贵重药品比例小于或者等于其对应的贵重药品比例上限，则可确定待监控医疗单位的用药是达标的，否则该医疗单位的用药则是超标的。
可选的，在一些可行的实施方式中，对待监控医疗单位的用药监控，也可在基于贵重药品比例的基础上，结合待监控医疗单位的日均药品费用进行综合评价。例如，只有在贵 重药品比例和日均药品费用都达标时，待监控医疗单位的药品费用才不超标等。同样的，在一些可行的实施方式中，针对不同医疗单位进行用药监控时，可基于各个医疗单位的特点设定各个医疗单位的用药评价标准的考核指标阈值，例如日均药品费用的达标上限，或称日均药品费用阈值等。例如，基于不同地域、不同城市、不同药品供应渠道或者不同病患流动量等参数所关联的不同医疗单元，药品评价标准的考核指标阈值可不尽相同。例如，对于物价较高的城市所关联的医疗单位或者药品供应渠道所带来的药品成本价较高所关联的医疗单元，则可将其日均药品费用的达标上限设置得较高一些，即其对应的用药评价标准的考核指标阈值则可设定为较高的考核指标等等。进而可基于上述确定的待监控医疗单位的日均药品费用，结合该医疗单位对应的考核指标阈值确定该医疗单位的用药标准是否达标，换句话说，就是待监控医疗单位的日均药品费用是否低于或者等于其对应的日均药品费用阈值。进而可在待监控医疗单位的日均药品费用达标，同时贵重药品比例也达标时，才确定该医疗单位的用药是达标的，否则确定待监控医疗单位的用药超标。具体可根据实际应用场景确定，在此不做限制。
基于本申请实施例提供的方法实现对各医疗单位的用药监控操作方式多样，既可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，同时也可增强对医疗单位的用药监控的操作灵活性，适用性更强。
实施例三：
参见图3，图3是本申请实施例提供的基于数据处理的用药监控装置的实施例结构示意图。本申请实施例提供的基于数据处理的用药监控装置包括：
数据获取单元31，用于获取待监控医疗单位的用药处方。
药品信息处理单元32，用于获取上述数据获取单元31获取的上述用药处方中所包括的各类药品的药品信息，并根据上述各类药品的药品信息确定上述各类药品的单药日均药品费用。
上述药品信息处理单元32，还用于根据上述各类药品的单药日均药品费用确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定出上述目标药品在上述用药处方的目标药品比例。
用药评价单元33，用于根据上述药品信息处理单元32确定的上述目标药品比例和上述待监控医疗单位对应的用药标准阈值，确定上述待监控医疗单位的用药是否达标。
在一些可行的实施方式中，上述数据获取单元31用于：
获取上述待监控医疗单位的数据系统准入资格，基于上述数据系统准入资格从上述待监控医疗单位的数据系统中获取上述待监控医疗单位的用药处方；和/或
获取上述待监控医疗单位提供的医疗理赔数据，从上述医疗理赔数据中获取上述待监控医疗单位的用药处方；
其中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在单个考核周期内的 所有用药处方，上述单个考核周期的周期时长包括一日或者多日。
在一些可行的实施方式中，上述药品信息处理单元32用于：
获取上述所有用药处方中所包括的各类药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数；
根据上述各类药品的药品信息确定出上述用药处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数；
根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用；
其中，上述任一类药品的单药日均药品费用满足：
单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
在一些可行的实施方式中，上述药品信息处理单元32用于：
根据上述各类药品的单药日均药品费用确定出上述用药处方对应的单药日均药品费用阈值，并将上述各类药品中单药日均药品费用大于或者等于上述单药日均药品费用阈值的药品确定为上述用药处方中的目标药品。
在一些可行的实施方式中，上述药品信息处理单元32用于：
根据上述各类药品的药品信息确定出上述用药处方中所有药品的药品总额，以及上述用药处方中所包括的上述目标药品的目标药品总额；
根据上述所有药品的药品总额和上述目标药品总额确定出上述用药处方的目标药品比例；
其中，上述目标药品比例满足：
目标药品比例＝目标药品总额/所有药品的药品总额。
在一些可行的实施方式中，上述药品信息处理单元32还用于：
根据上述待监控医疗单位的单位属性信息确定上述待监控医疗单位的目标药品比例上限，并将上述目标药品比例上限确定为上述待监控医疗单位的用药标准阈值；
其中，上述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种。
在一些可行的实施方式中，上述用药评价单元33用于：
在上述药品信息处理单元32确定的上述待监控医疗单位的目标药品比例小于或者等于上述目标药品比例上限时，确定上述待监控医疗单位的用药达标；
若上述待监控医疗单位的目标药品比例大于上述目标药品比例上限，则确定上述待监控医疗单位的用药不达标。
在一些可行的实施方式中，上述基于数据处理的用药监控装置可通过其内置的各个功能模块执行如上述图1至图2中各个步骤所提供的实现方式。可选的，上述基于数据处理的用药监控装置可为上述各个实施例中所描述的终端设备，在此不做限制。
本申请实施例既可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，同时也可增强对医疗单位的用药监控的操作灵活性，适用性更强。
实施例四：
参见图4，图4是本申请实施例提供的终端设备的实施例结构示意图。如图4所示，本实施例中的终端设备可以包括：一个或多个处理器401和存储器402。上述处理器401和存储器402通过总线403连接。存储器402用于存储计算机程序，该计算机程序包括程序指令，处理器401用于执行存储器402存储的程序指令。其中，上述处理器401被配置用于调用该程序指令执行如下操作：
获取待监控医疗单位的用药处方；
获取上述用药处方中所包括的各类药品的药品信息，并根据上述各类药品的药品信息确定上述各类药品的单药日均药品费用；
根据上述各类药品的单药日均药品费用确定出上述用药处方中的目标药品，并根据上述各类药品的药品信息确定出上述目标药品在上述用药处方的目标药品比例；
根据上述目标药品比例和上述待监控医疗单位对应的用药标准阈值，确定上述待监控医疗单位的用药是否达标。
在一些可行的实施方式中，上述处理器401，用于：
获取上述待监控医疗单位的数据系统准入资格，基于上述数据系统准入资格从上述待监控医疗单位的数据系统中获取上述待监控医疗单位的用药处方；和/或
获取上述待监控医疗单位提供的医疗理赔数据，从上述医疗理赔数据中获取上述待监控医疗单位的用药处方；
其中，上述待监控医疗单位的用药处方包括上述待监控医疗单位在单个考核周期内的所有用药处方，上述单个考核周期的周期时长包括一日或者多日。
在一些可行的实施方式中，上述处理器401，用于：
获取上述所有用药处方中所包括的各类药品的药品信息，上述药品信息中至少包括药品金额和药品使用天数；
根据上述各类药品的药品信息确定出上述用药处方中任一类药品的药品总额以及上述任一类药品的药品使用总天数；
根据上述任一类药品的药品总额和上述任一类药品的药品使用总天数确定上述任一类药品的单药日均药品费用以得到上述各类药品的单药日均药品费用；
其中，上述任一类药品的单药日均药品费用满足：
单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
在一些可行的实施方式中，上述处理器401，用于：
根据上述各类药品的单药日均药品费用确定出上述用药处方对应的单药日均药品费用阈值，并将上述各类药品中单药日均药品费用大于或者等于上述单药日均药品费用阈值的 药品确定为上述用药处方中的目标药品。
在一些可行的实施方式中，上述处理器401，用于：
根据上述各类药品的药品信息确定出上述用药处方中所有药品的药品总额，以及上述用药处方中所包括的上述目标药品的目标药品总额；
根据上述所有药品的药品总额和上述目标药品总额确定出上述用药处方的目标药品比例；
其中，上述目标药品比例满足：
目标药品比例＝目标药品总额/所有药品的药品总额。
在一些可行的实施方式中，上述处理器401还用于：
根据上述待监控医疗单位的单位属性信息确定上述待监控医疗单位的目标药品比例上限，并将上述目标药品比例上限确定为上述待监控医疗单位的用药标准阈值；
其中，上述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种。
在一些可行的实施方式中，上述处理器401，用于：
在上述待监控医疗单位的目标药品比例小于或者等于上述目标药品比例上限时，确定上述待监控医疗单位的用药达标；
在上述待监控医疗单位的目标药品比例大于上述目标药品比例上限时，确定上述待监控医疗单位的用药不达标。
在一些可行的实施方式中，上述处理器401可以是中央处理单元(central processing unit，CPU)，该处理器还可以是其他通用处理器、数字信号处理器(digital signal processor，DSP)、专用集成电路(application specific integrated circuit，ASIC)、现成可编程门阵列(field-programmable gate array，FPGA)或者其他可编程逻辑器件、分立门或者晶体管逻辑器件、分立硬件组件等。通用处理器可以是微处理器或者该处理器也可以是任何常规的处理器等。
该存储器402可以包括只读存储器和随机存取存储器，并向处理器401提供指令和数据。存储器402的一部分还可以包括非易失性随机存取存储器。例如，存储器402还可以存储设备类型的信息。
在一些可行的实施方式中，上述终端设备可通过其内置的处理器401各个功能模块执行如上述图1至图2中各个步骤所提供的实现方式，具体可参见上述各个步骤所提供的实现方式，在此不再赘述。
本申请实施例可实现对各医疗单位的用药监控操作方式多样，既可提高对医疗单位的用药监控的准确性，提高对医疗单位的用药监控的可靠性，同时也可增强对医疗单位的用药监控的操作灵活性，适用性更强。
本申请实施例还提供一种计算机可读存储介质，该计算机可读存储介质存储有计算机 程序，该计算机程序包括程序指令，该程序指令被处理器执行时实现图1至图2中各个步骤所提供的基于数据处理的用药监控方法，具体可参见上述各个步骤所提供的实现方式，在此不再赘述。
上述计算机可读存储介质可以是前述任一实施例提供的基于数据处理的用药监控装置或者上述终端设备的内部存储单元，例如电子设备的硬盘或内存。该计算机可读存储介质也可以是该电子设备的外部存储设备，例如该电子设备上配备的插接式硬盘，智能存储卡(smart media card,SMC)，安全数字(secure digital,SD)卡，闪存卡(flash card)等。
以上所述，仅为本申请的具体实施方式，但本申请的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本申请揭露的技术范围内，可轻易想到变化或替换，都应涵盖在本申请的保护范围之内。因此，本申请的保护范围应以所述权利要求的保护范围为准。

Claims (20)

  1. 一种基于数据处理的用药监控方法，其特征在于，所述方法包括：
    获取待监控医疗单位的用药处方；
    获取所述用药处方中所包括的各类药品的药品信息，并根据所述各类药品的药品信息确定所述各类药品的单药日均药品费用；
    根据所述各类药品的单药日均药品费用确定出所述用药处方中的目标药品，并根据所述各类药品的药品信息确定出所述目标药品在所述用药处方的目标药品比例；
    根据所述目标药品比例和所述待监控医疗单位对应的用药标准阈值，确定所述待监控医疗单位的用药是否达标。
  2. 根据权利要求1所述的方法，其特征在于，所述获取待监控医疗单位的用药处方包括：
    获取所述待监控医疗单位的数据系统准入资格，基于所述数据系统准入资格从所述待监控医疗单位的数据系统中获取所述待监控医疗单位的用药处方；和/或
    获取所述待监控医疗单位提供的医疗理赔数据，从所述医疗理赔数据中获取所述待监控医疗单位的用药处方；
    其中，所述待监控医疗单位的用药处方包括所述待监控医疗单位在单个考核周期内的所有用药处方，所述单个考核周期的周期时长包括一日或者多日。
  3. 根据权利要求1或2所述的方法，其特征在于，所述获取所述用药处方中所包括的各类药品的药品信息，并根据所述各类药品的药品信息确定所述各类药品的单药日均药品费用包括：
    获取所述所有用药处方中所包括的各类药品的药品信息，所述药品信息中至少包括药品金额和药品使用天数；
    根据所述各类药品的药品信息确定出所述用药处方中任一类药品的药品总额以及所述任一类药品的药品使用总天数；
    根据所述任一类药品的药品总额和所述任一类药品的药品使用总天数确定所述任一类药品的单药日均药品费用以得到所述各类药品的单药日均药品费用；
    其中，所述任一类药品的单药日均药品费用满足：
    单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
  4. 根据权利要求3所述的方法，其特征在于，所述根据所述各类药品的单药日均药品费用确定出所述用药处方中的目标药品包括：
    根据所述各类药品的单药日均药品费用确定出所述用药处方对应的单药日均药品费用阈值，并将所述各类药品中单药日均药品费用大于或者等于所述单药日均药品费用阈值的药品确定为所述用药处方中的目标药品。
  5. 根据权利要求4所述的方法，其特征在于，所述根据所述各类药品的药品信息确定出所述目标药品在所述用药处方的目标药品比例包括：
    根据所述各类药品的药品信息确定出所述用药处方中所有药品的药品总额，以及所述用药处方中所包括的所述目标药品的目标药品总额；
    根据所述所有药品的药品总额和所述目标药品总额确定出所述用药处方的目标药品比例；
    其中，所述目标药品比例满足：
    目标药品比例＝目标药品总额/所有药品的药品总额。
  6. 根据权利要求1-5任一项所述的方法，其特征在于，所述方法还包括：
    根据所述待监控医疗单位的单位属性信息确定所述待监控医疗单位的目标药品比例上限，并将所述目标药品比例上限确定为所述待监控医疗单位的用药标准阈值；
    其中，所述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种。
  7. 根据权利要求6所述的方法，其特征在于，所述根据所述目标药品比例和所述待监控医疗单位对应的用药标准阈值，确定所述待监控医疗单位的用药是否达标包括：
    若所述目标药品比例小于或者等于所述目标药品比例上限，则确定所述待监控医疗单位的用药达标；
    若所述目标药品比例大于所述目标药品比例上限，则确定所述待监控医疗单位的用药不达标。
  8. 一种基于数据处理的用药监控装置，其特征在于，所述装置包括：
    数据获取单元，用于获取待监控医疗单位的用药处方；
    药品信息处理单元，用于获取所述数据获取单元获取的所述用药处方中所包括的各类药品的药品信息，并根据所述各类药品的药品信息确定所述各类药品的单药日均药品费用；
    所述药品信息处理单元，还用于根据所述各类药品的单药日均药品费用确定出所述用药处方中的目标药品，并根据所述各类药品的药品信息确定出所述目标药品在所述用药处方的目标药品比例；
    用药评价单元，用于根据所述药品信息处理单元确定的所述目标药品比例，和所述待监控医疗单位对应的用药标准阈值确定所述待监控医疗单位的用药是否达标。
  9. 根据权利要求8所述的装置，其特征在于，所述数据获取单元用于：
    获取所述待监控医疗单位的数据系统准入资格，基于所述数据系统准入资格从所述待监控医疗单位的数据系统中获取所述待监控医疗单位的用药处方；和/或
    获取所述待监控医疗单位提供的医疗理赔数据，从所述医疗理赔数据中获取所述待监控医疗单位的用药处方；
    其中，所述待监控医疗单位的用药处方包括所述待监控医疗单位在单个考核周期内的 所有用药处方，所述单个考核周期的周期时长包括一日或者多日。
  10. 根据权利要求8或9所述的装置，其特征在于，所述药品信息处理单元用于：
    获取所述所有用药处方中所包括的各类药品的药品信息，所述药品信息中至少包括药品金额和药品使用天数；
    根据所述各类药品的药品信息确定出所述用药处方中任一类药品的药品总额以及所述任一类药品的药品使用总天数；
    根据所述任一类药品的药品总额和所述任一类药品的药品使用总天数确定所述任一类药品的单药日均药品费用以得到所述各类药品的单药日均药品费用；
    其中，所述任一类药品的单药日均药品费用满足：
    单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
  11. 根据权利要求10所述的装置，其特征在于，所述药品信息处理单元用于：
    根据所述各类药品的单药日均药品费用确定出所述用药处方对应的单药日均药品费用阈值，并将所述各类药品中单药日均药品费用大于或者等于所述单药日均药品费用阈值的药品确定为所述用药处方中的目标药品。
  12. 根据权利要求11所述的装置，其特征在于，所述药品信息处理单元用于：
    根据所述各类药品的药品信息确定出所述用药处方中所有药品的药品总额，以及所述用药处方中所包括的所述目标药品的目标药品总额；
    根据所述所有药品的药品总额和所述目标药品总额确定出所述用药处方的目标药品比例；
    其中，所述目标药品比例满足：
    目标药品比例＝目标药品总额/所有药品的药品总额。
  13. 根据权利要求8-12任一项所述的装置，其特征在于，所述药品信息处理单元还用于：
    根据所述待监控医疗单位的单位属性信息确定所述待监控医疗单位的目标药品比例上限，并将所述目标药品比例上限确定为所述待监控医疗单位的用药标准阈值；
    其中，所述待监控医疗单位的单位属性信息包括单位类型、单位所处地域、单位所处城市、单位药品供应渠道以及单位病患人次中的一种或多种。
  14. 根据权利要求13所述的装置，其特征在于，所述用药评价单元用于：
    在所述药品信息处理单元确定的所述待监控医疗单位的目标药品比例小于或者等于所述目标药品比例上限时，确定所述待监控医疗单位的用药达标；
    若所述待监控医疗单位的目标药品比例大于所述目标药品比例上限，则确定所述待监控医疗单位的用药不达标。
  15. 一种终端设备，其特征在于，包括处理器和存储器，所述处理器和存储器相互连接，其中，所述存储器用于存储计算机程序，所述计算机程序包括程序指令，所述处理器被配置用于调用所述程序指令，执行如下操作：
    获取待监控医疗单位的用药处方；
    获取所述用药处方中所包括的各类药品的药品信息，并根据所述各类药品的药品信息确定所述各类药品的单药日均药品费用；
    根据所述各类药品的单药日均药品费用确定出所述用药处方中的目标药品，并根据所述各类药品的药品信息确定出所述目标药品在所述用药处方的目标药品比例；
    根据所述目标药品比例和所述待监控医疗单位对应的用药标准阈值，确定所述待监控医疗单位的用药是否达标。
  16. 根据权利要求15所述的终端设备，其特征在于，所述处理器用于：
    获取所述待监控医疗单位的数据系统准入资格，基于所述数据系统准入资格从所述待监控医疗单位的数据系统中获取所述待监控医疗单位的用药处方；和/或
    获取所述待监控医疗单位提供的医疗理赔数据，从所述医疗理赔数据中获取所述待监控医疗单位的用药处方；
    其中，所述待监控医疗单位的用药处方包括所述待监控医疗单位在单个考核周期内的所有用药处方，所述单个考核周期的周期时长包括一日或者多日。
  17. 根据权利要求15或16所述的终端设备，其特征在于，所述处理器用于：
    获取所述所有用药处方中所包括的各类药品的药品信息，所述药品信息中至少包括药品金额和药品使用天数；
    根据所述各类药品的药品信息确定出所述用药处方中任一类药品的药品总额以及所述任一类药品的药品使用总天数；
    根据所述任一类药品的药品总额和所述任一类药品的药品使用总天数确定所述任一类药品的单药日均药品费用以得到所述各类药品的单药日均药品费用；
    其中，所述任一类药品的单药日均药品费用满足：
    单药日均药品费用＝任一类药品的药品总额/任一类药品的药品使用总天数。
  18. 根据权利要求17所述的终端设备，其特征在于，所述处理器用于：
    根据所述各类药品的单药日均药品费用确定出所述用药处方对应的单药日均药品费用阈值，并将所述各类药品中单药日均药品费用大于或者等于所述单药日均药品费用阈值的药品确定为所述用药处方中的目标药品。
  19. 根据权利要求18所述的终端设备，其特征在于，所述处理器用于：
    根据所述各类药品的药品信息确定出所述用药处方中所有药品的药品总额，以及所述用药处方中所包括的所述目标药品的目标药品总额；
    根据所述所有药品的药品总额和所述目标药品总额确定出所述用药处方的目标药品比例；
    其中，所述目标药品比例满足：
    目标药品比例＝目标药品总额/所有药品的药品总额。
  20. 一种计算机可读存储介质，其特征在于，所述计算机可读存储介质存储有计算机程序，所述计算机程序被处理器执行以实现权利要求1-7任一项所述的方法。
PCT/CN2019/094997 2018-10-22 2019-07-08 基于数据处理的用药监控方法及装置 WO2020082786A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201811234422.X 2018-10-22
CN201811234422.XA CN109524080A (zh) 2018-10-22 2018-10-22 基于数据处理的用药监控方法及装置

Publications (1)

Publication Number Publication Date
WO2020082786A1 true WO2020082786A1 (zh) 2020-04-30

Family

ID=65772347

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/094997 WO2020082786A1 (zh) 2018-10-22 2019-07-08 基于数据处理的用药监控方法及装置

Country Status (2)

Country Link
CN (1) CN109524080A (zh)
WO (1) WO2020082786A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109524079A (zh) * 2018-10-22 2019-03-26 平安医疗健康管理股份有限公司 基于数据处理的药品费用风险控制方法及装置
CN109524080A (zh) * 2018-10-22 2019-03-26 平安医疗健康管理股份有限公司 基于数据处理的用药监控方法及装置
CN111063412A (zh) * 2019-11-07 2020-04-24 索宁 一种用药监控方法、装置及系统

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106485391A (zh) * 2015-11-09 2017-03-08 中国人民解放军总医院第附属医院 医保信息共享综合管理系统
CN107833621A (zh) * 2017-03-06 2018-03-23 平安医疗健康管理股份有限公司 医疗费用控制方法和装置
US20180190385A1 (en) * 2013-07-31 2018-07-05 Elwha Llc Generating a description of, and an offer to transfer or a solicitation of an offer to acquire, an asset that includes at least one retreatment contract
CN109524080A (zh) * 2018-10-22 2019-03-26 平安医疗健康管理股份有限公司 基于数据处理的用药监控方法及装置

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103514576A (zh) * 2013-09-06 2014-01-15 深圳民太安信息技术有限公司 一种社保就诊违规套现的筛查方法
CN103971217A (zh) * 2014-02-24 2014-08-06 浙江大学 一种药品库存管理方法及系统
CN108492856A (zh) * 2018-03-23 2018-09-04 顾泰来 一种处方提交装置、终端及方法
CN108648792A (zh) * 2018-05-04 2018-10-12 河北省人民医院 用药信息管理系统、方法及终端设备

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180190385A1 (en) * 2013-07-31 2018-07-05 Elwha Llc Generating a description of, and an offer to transfer or a solicitation of an offer to acquire, an asset that includes at least one retreatment contract
CN106485391A (zh) * 2015-11-09 2017-03-08 中国人民解放军总医院第附属医院 医保信息共享综合管理系统
CN107833621A (zh) * 2017-03-06 2018-03-23 平安医疗健康管理股份有限公司 医疗费用控制方法和装置
CN109524080A (zh) * 2018-10-22 2019-03-26 平安医疗健康管理股份有限公司 基于数据处理的用药监控方法及装置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
陈卫华 (CHEN, WEIHUA): "医保处方监控系统的设计与实现 (Design and Implementation of Medicare Prescription Monitoring System)", 中国优秀硕士学位论文全文数据库 信息科技辑 (CHINESE MASTER’S THESES FULL-TEXT DATABASE, INFORMATION SCIENCE AND TECHNOLOGY), no. 10, 15 October 2011 (2011-10-15), ISSN: 1674-0246 *

Also Published As

Publication number Publication date
CN109524080A (zh) 2019-03-26

Similar Documents

Publication Publication Date Title
Modarai et al. Relationship of opioid prescription sales and overdoses, North Carolina
WO2020082786A1 (zh) 基于数据处理的用药监控方法及装置
WO2020082797A1 (zh) 基于数据处理的药品费用超标预警方法及装置
Nebeker et al. High rates of adverse drug events in a highly computerized hospital
Weycker et al. Prevalence and economic burden of bronchiectasis
Field et al. The costs associated with adverse drug events among older adults in the ambulatory setting
Rottenkolber et al. Costs of adverse drug events in German hospitals—a microcosting study
US8768724B2 (en) System and method for detecting drug fraud and abuse
White et al. Characteristics of patients who return to the emergency department within 72 hours in one community hospital
Chua et al. Naloxone and buprenorphine prescribing following US emergency department visits for suspected opioid overdose: August 2019 to April 2021
US20190074077A1 (en) Prescription management system and method
CN109509104A (zh) 基于人脸识别的身份认证方法、装置、服务器及介质
US10489717B2 (en) System and method for pharmacovigilance
US8744872B1 (en) System and method for pharmacovigilance
Taegtmeyer et al. Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting
WO2020082783A1 (zh) 基于数据处理的药品费用控制方法及装置
WO2020082785A1 (zh) 基于数据处理的用药处方风险控制方法及装置
CN109559795B (zh) 基于数据处理的违规处方单的检测方法及相关设备
US11424040B2 (en) System and method for pharmacovigilance
WO2020082791A1 (zh) 基于数据处理的药品费用超标的风险控制方法及装置
JP4105571B2 (ja) 医療ネットワークサーバ及び医療ネットワークシステム
WO2020082802A1 (zh) 基于数据处理的药品费用风险控制方法及装置
WO2020082792A1 (zh) 基于数据处理的医疗单位用药监控方法及装置
Mabotuwana et al. A computational framework to identify patients with poor adherence to blood pressure lowering medication
CN111312357B (zh) 一种药品分析方法及系统

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19875606

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19875606

Country of ref document: EP

Kind code of ref document: A1

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 22/12/2021)

122 Ep: pct application non-entry in european phase

Ref document number: 19875606

Country of ref document: EP

Kind code of ref document: A1